Feasibility Study: Heavy Water Tissue Labeling Protocol

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Skin Laxity
Interventions
DEVICE

Ulthera® System Treatment

Focused ultrasound energy delivered below the surface of the skin

OTHER

Heavy Water

A tissue labeling model via the consumption of the stable isotope, deuterated water (heavy water). Heavy water consumed over the course of the 6-week study period for a direct kinetic measure of in vivo collagen synthesis. 60 ml (about 12 teaspoons) of heavy water (also called deuterated water or 2H2O), was consumed three times a day for the first five days. Starting on Day 6, two 60 ml doses of heavy water were consumed per day for the remaining 37 days.

Trial Locations (1)

91105

Sasaki Advanced Aesthetic Medical Center, Pasadena

All Listed Sponsors
lead

Ulthera, Inc

INDUSTRY

NCT01708525 - Feasibility Study: Heavy Water Tissue Labeling Protocol | Biotech Hunter | Biotech Hunter